Original Articles

M Wagner, CG Morris, JD Reith, MT Scarborough, WM Mendenhall

Hong Kong J Radiol 2006;9:15-20

Objective: To report outcomes after radiotherapy used to treat diffuse pigmented villonodular synovitis.

Patients and Methods: Between 1969 and 2000, 4 patients with pigmented villonodular synovitis were treated with radiotherapy at the Department of Radiation Oncology, Health Science Center, University

Full Article

TJ Galloway, RJ Amdur, CG Morris, AR Yeung, WM Mendenhall

Hong Kong J Radiol 2010;12:154-61

Objective: To determine if the use of more complex technology in the form of 3-dimensional treatment planning improved outcomes after primary radiotherapy for early-stage cervical cancer.

Full Article

JYH Hui, AXN Lo, AWS Au Yeung, MKW Yang, SWW Chan, SH Lam, NWF Yuen, JCS Chan

Hong Kong J Radiol 2010;12:147-53

Objective: To evaluate potential benefits and patient acceptance of the one-stop breast imaging service in a regional hospital in Hong Kong.

Methods: A total of 87 patients referred from the new-case surgical breast clinic for one-stop breast imaging were prospectively

Full Article

ESK Ma, CLP Wong

Hong Kong J Radiol 2010;13(Suppl):S42-50

Cancer biomarkers have evolved from assays based on proteins, hormones and enzymes to molecular assays based on DNA or RNA. These molecular cancer biomarkers have broad clinical applications in disease screening, diagnosis, classification, offering a

Full Article

RKC Ngan

Hong Kong J Radiol 2010;13(Suppl):S33-41

The GOG111 and OV-10 were pivotal studies published in 1996 and 2000 respectively which established paclitaxel / cisplatin as standard postoperative adjuvant chemotherapy for advanced epithelial ovarian cancers. A second major breakthrough in the ensuing

Full Article

J Tsang

Hong Kong J Radiol 2010;13(Suppl):S29-32

Glioblastoma multiforme is a highly invasive and aggressive brain tumour. It is the most commonly seen glioma with fast-growing features, being a devastating disease with no clear causation and no means of early detection. Less than 10% of glioblastoma

Full Article

W Yeo

Hong Kong J Radiol 2010;13(Suppl):S25-8

Gastric cancer is the fourth commonest cancer worldwide, with nearly a million new patients being diagnosed with this disease per year, of whom 55% are in East Asia. Regrettably, despite the availability of potentially curative resection, between 50 and 90% of

Full Article

E Tse, YL Kwong

Hong Kong J Radiol 2010;13(Suppl):S22-4

Malignant lymphoma is a common neoplasm and some are potentially curable if appropriate therapy is given. The use of the monoclonal anti-CD20 antibody rituximab in the management of follicular lymphoma has improved the outcome of patients.

Full Article

VHF Lee

Hong Kong J Radiol 2010;13(Suppl):S16-21

Systemic chemotherapy has been the standard treatment for advanced / metastatic non–small-cell lung cancer, particularly in those who do not harbour an epidermal growth factor receptor mutation. In the last decade, there was no established evidence to justify

Full Article

ML Zhuo, J Wang

Hong Kong J Radiol 2010;13(Suppl):S10-5

The epidermal growth factor receptor tyrosine kinase inhibitors, including gefitinib and erlotinib, have been proven to provide significant benefit in progression-free survival and overall survival in patients who have received at least one line of prior